The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
Open accessAbstract
Circular RNAs (circRNAs) represent a widespread class of non-coding RNAs generated from back-splicing, with a circular loop structure. Many circRNAs have been reported to play essential roles in cancer development and have the potential to serve as a novel class of biomarkers for clinical diagnosis. However, the role of circRNA in osteosarcoma (OS) remains largely unknown. In the current study, we examined the expression level of circular RNA PVT1 (circPVT1), previously screened and identified the oncogenic role in gastric cancer, in OS and found that circPVT1 was significantly up-regulated in the OS tissues, serums and chemoresistant cell lines, correlated with poor prognosis of OS patients. Besides, ROC curve demonstrated that circPVT1 may be a better diagnostic biomarker than alkaline phosphatase (ALP) in OS with more sensitivity and specificity. In addition, functional assays revealed that circPVT1 knockdown by siRNA could weaken the resistance to doxorubicin and cisplatin of OS cells through decreasing the expression of classical drug resistance-related gene ABCB1. These findings may provide a new insight into the role of circPVT1 as a biomarker for the diagnosis and treatment target of OS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
Chen, L., Zhang, S., Wu, J., Cui, J., Zhong, L., Zeng, L., & Ge, S. (2017) · Oncogene · doi:10.1038/onc.2017.89 · Cited by 392
RetractedHan, Z., & Shi, L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.121 · Cited by 118
RetractedLourda, M., Trougakos, I. P., & Gonos, E. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22327 · Cited by 86
RetractedBiochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Regulation of circRNA biogenesis
Chen, L.-L., & Yang, L. (2015) · RNA Biology · doi:10.1080/15476286.2015.1020271 · Cited by 1,953
Circular RNA: a new star of noncoding RNAs
Qu, S., Yang, X., Li, X., Wang, J., Gao, Y., Shang, R., Sun, W., Dou, K., & Li, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.003 · Cited by 1,808 · cited 1×
“With the rapid development in the RNA-seq technology, more and more non-coding RNAs previously termed as “junk molecule” were screened and identified, such as long non-coding RNA (lncRNA) and circular RNA (circRNA)[5].”
BackgroundOsteosarcoma: Current Treatment and a Collaborative Pathway to Success
Isakoff, M. S., Bielack, S. S., Meltzer, P., & Gorlick, R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,567
CircRNA: functions and properties of a novel potential biomarker for cancer
Meng, S., Zhou, H., Feng, Z., Xu, Z., Tang, Y., Li, P., & Wu, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0663-2 · Cited by 1,521
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
THE JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Şenol, V., Ünalan, D., Akça, R. P., & Baştürk, M. (2018) · Cited by 896
Circular RNAs: analysis, expression and potential functions
Barrett, S. P., & Salzman, J. (2016) · Development · doi:10.1242/dev.128074 · Cited by 859
Circular RNA Expression: Its Potential Regulation and Function
Salzman, J. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.002 · Cited by 804
CircRNA: a novel type of biomarker for cancer
Zhang, H.-D., Jiang, L.-H., Sun, D.-W., Hou, J.-C., & Ji, Z.-L. (2018) · Breast Cancer · doi:10.1007/s12282-017-0793-9 · Cited by 760
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
Kulcheski, F. R., Christoff, A. P., & Margis, R. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.09.011 · Cited by 740
Chen, J., Li, Y., Zheng, Q., Bao, C., He, J., Chen, B., Lyu, D., Zheng, B., Xu, Y., Long, Z., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.006 · Cited by 686
Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis
Hsiao, K.-Y., Lin, Y.-C., Gupta, S. K., Chang, N., Yen, L., Sun, H. S., & Tsai, S.-J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1883 · Cited by 669
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Circular RNAs: Identification, biogenesis and function
Ebbesen, K. K., Kjems, J., & Hansen, T. B. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.007 · Cited by 558
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
Geller, D. S., & Gorlick, R. G. (2010) · PubMed · Cited by 475
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Qin, M., Liu, G., Huo, X., Tao, X., Sun, X., Ge, Z., Yang, J., Fan, J., Liu, L., & Qin, W. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150552 · Cited by 441
Circular RNAs in cancer: novel insights into origins, properties, functions and implications.
Li, J., Yang, J., Zhou, P., Le, Y., Zhou, C., Wang, S., Xu, D., Lin, H., & Gong, Z. (2015) · Europe PMC (PubMed Central) · Cited by 435
Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer
Chen, S., Li, T., Zhao, Q., Xiao, B., & Guo, J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.01.025 · Cited by 378
Moore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Shang, X., Li, G., Liu, H., Li, T., Liu, J., Zhao, Q., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000003811 · Cited by 330
hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma
Zhu, X., Wang, X., Wei, S., Chen, Y., Chen, Y., Fan, X., Han, S., & Wu, G. (2017) · The FEBS Journal · doi:10.1111/febs.14132 · Cited by 295
Zhang, Y., Liu, H., Li, W., Yu, J., Li, J., Shen, Z., Ye, G., Qi, X., & Li, G. (2017) · Aging · doi:10.18632/aging.101254 · Cited by 294
Panda, A. C., Grammatikakis, I., Kim, K. M., De, S., Martindale, J. L., Munk, R., Yang, X., Abdelmohsen, K., & Gorospe, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1201 · Cited by 252
Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value
Yao, J.-T., Zhao, S.-H., Liu, Q.-P., Lv, M.-Q., Zhou, D.-X., Liao, Z.-J., & Nan, K.-J. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.02.011 · Cited by 249
Circular RNAs: emerging cancer biomarkers and targets
Zhang, Y., Liang, W., Zhang, P., Chen, J., Qian, H., Zhang, X., & Xu, W. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0624-z · Cited by 226
Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer
Huang, M., He, Y.-R., Liang, L.-C., Huang, Q., & Zhu, Z.-Q. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i34.6330 · Cited by 200
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
Shang, Y., Zhang, Z., Liu, Z., Feng, B., Ren, G., Li, K., Zhou, L., Sun, Y., Li, M., Zhou, J., et al. (2014) · Oncogene · doi:10.1038/onc.2013.297 · Cited by 188
Lü, L., Sun, J., Shi, P., Kong, W., Xu, K., He, B., Zhang, S., & Wang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17307 · Cited by 181
Song, J., Wu, X., Liu, F., Li, M., Sun, Y., Wang, Y., Wang, C., Zhu, K., Jia, X., Wang, B., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.024 · Cited by 174
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
Morrow, J. J., & Khanna, C. (2015) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2015013713 · Cited by 172
Susa, M., Iyer, A. K., Ryu, K., Hornicek, F. J., Mankin, H., Amiji, M. M., & Duan, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-399 · Cited by 164
Bruhn, O., & Cascorbi, I. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.952630 · Cited by 161
Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma
Sun, H., Tang, W., Rong, D., Jin, H. Z., Fu, K., Zhang, W., Liu, Z., Cao, H., & Cao, X. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170379 · Cited by 150
Wang, Y., Zhang, D., Wu, K., Zhao, Q., Nie, Y., & Fan, D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-13 · Cited by 148
Reduced expression of circ RNA hsa_circ_0003159 in gastric cancer and its clinical significance
Tian, M., Chen, R., Li, T., & Xiao, B. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22281 · Cited by 148
Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression
Zhang, H., Wang, G., Ding, C., Liu, P., Wang, R., Ding, W., Tong, D., Wu, D.-D., Li, C., Wei, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18671 · Cited by 148
Sui, H. X., Fan, Z.-Z., & Li, Q. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000204 · Cited by 145
Advances in targeted therapy for osteosarcoma.
Zhou, W., Hao, M., Du, X., Chen, K., Wang, G., & Yang, J. (2014) · PubMed · Cited by 138
Zhou, Q., Chen, F., Zhao, J., Li, B., Liang, Y., Pan, W., Zhang, S., Wang, X., & Zheng, D. (2016) · Oncotarget · doi:10.18632/oncotarget.13012 · Cited by 130
Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma
Liu, W., Zhang, J., Zou, C., Xie, X., Wang, Y., Wang, B., Zhao, Z., Tu, J., Wang, X., Li, H., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481650 · Cited by 125
Deng, N. H., Li, L., Gao, J., Zhou, J., Wang, Y., Wang, C., & Liu, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.028 · Cited by 112
Circular RNAs: A novel type of biomarker and genetic tools in cancer
Han, Y., Xia, S., Zhang, Y., Zheng, J., & Li, W. (2017) · Oncotarget · doi:10.18632/oncotarget.18350 · Cited by 105
Zhu, Q.-N., Wang, G., Guo, Y., Peng, Y., Zhang, R., Deng, J., Li, Z., & Zhu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21121 · Cited by 98
Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances
Shao, Y., Chen, L., Lu, R., Zhang, X., Xiao, B., Ye, G., & Guo, J. (2017) · Tumor Biology · doi:10.1177/1010428317699125 · Cited by 89
Ren, H., Sun, L., Li, H., & Ye, Z. (2015) · BioMed Research International · doi:10.1155/2015/160835 · Cited by 88
Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells
Jin, H., Jin, X., Zhang, H., & Wang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.16104 · Cited by 84
Sun, K., Jiao, J., Chen, S., Liu, B., & Zhao, Y. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0207-6 · Cited by 71
Zhou, Y., Zhao, R., Tseng, K., Li, K., Lu, Z., Liu, Y., Han, K., Gan, Z.-H., Lin, S., Hu, H., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.153 · Cited by 61
Zhao, Y., Zhang, C.-L., Zeng, B.-F., Wu, X.-S., Gao, T.-T., & Oda, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.020 · Cited by 50
Li, J., & Song, Y.-Z. (2017) · Tumor Biology · doi:10.1177/1010428317709991 · Cited by 50
Cited by
Su, M., Xiao, Y., Ma, J., Tang, Y., Tian, B., Zhang, Y., Li, X., Wu, Z., Yang, D., Zhou, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1002-6 · Cited by 457
Bach, D.-H., Lee, S. K., & Sood, A. K. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.02.005 · Cited by 405
Metadata
- Authors
- Kun-Peng, Z., Xiao-Long, M., & Chun-Lin, Z.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 14
- Issue
- 3
- Pages
- 321-330
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2794160361
- Cited by
- 265
- References
- 54
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.